Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 65 of 1714:
55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75
Gene Compound Assay Inh Ic50 Ki View
potassium voltage-gated channel, subfamily H (eag-related), member 6 PENTAMIDINE Potassium Channel HERG 54% 15.7215uM 12.8802uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 PENTAMIDINE Potassium Channel HERG 54% 15.7215uM 12.8802uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 PENTAMIDINE Potassium Channel HERG 54% 15.7215uM 12.8802uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 PENTAMIDINE Potassium Channel HERG 54% 15.7215uM 12.8802uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 PENTAMIDINE Potassium Channel HERG 54% 15.7215uM 12.8802uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 PENTAMIDINE Potassium Channel HERG 54% 15.7215uM 12.8802uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 PENTAMIDINE Potassium Channel HERG 54% 15.7215uM 12.8802uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 PENTAMIDINE Potassium Channel HERG 54% 15.7215uM 12.8802uM View
cytochrome P450, family 3, subfamily a, polypeptide 13 FLUORESCEIN CYP450-3A4 Inhibition 54% NoneNone NoneNone View
chemokine (C-C motif) receptor 2 TRANS-PLATINUM(II)DIAMMINE DICHLORIDE Chemokine CCR2B 54% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 3,3',5-TRIIODO-L-THYRONINE Adrenergic, Norepinephrine Transporter 54% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase FLUNARIZINE CYP450-2C19 Inhibition 54% NoneNone NoneNone View
adrenergic receptor, alpha 1a SULOCTIDIL Adrenergic alpha1A 54% NoneNone NoneNone View
Sigma-2 Receptor AMBROXOL Sigma2 54% NoneNone NoneNone View
Protein-tyrosine kinase, Fyn FLUNARIZINE Protein Tyrosine Kinase, Fyn 54% NoneNone NoneNone View
dopamine receptor D4 DOMPERIDONE Dopamine D4.2 54% NoneNone NoneNone View
dopamine receptor D3 4-NONYLPHENOL Dopamine D3 54% NoneNone NoneNone View
dopamine receptor D3 HYDROXYPROGESTERONE Dopamine D3 54% NoneNone NoneNone View
dopamine receptor D1A HYDROXYPROGESTERONE Dopamine D1 54% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase MOCLOBEMIDE CYP450-2D6 Inhibition 54% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase SELEGILINE CYP450-2D6 Inhibition 54% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase MOSAPRIDE CYP450-2D6 Inhibition 54% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) ANISINDIONE CYP450-2C9 Inhibition 54% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 ANISINDIONE CYP450-2C9 Inhibition 54% NoneNone NoneNone View
acetylcholinesterase (YT blood group) HYDROXYPROGESTERONE Acetylcholinesterase 54% NoneNone NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase HYDROXYPROGESTERONE Acetylcholinesterase 54% NoneNone NoneNone View
acetylcholinesterase HYDROXYPROGESTERONE Acetylcholinesterase 54% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 3 polypeptide 3,3',4',5-TETRACHLOROSALICYLANILIDE ATPase, Na+/K+ 54% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 2 polypeptide 3,3',4',5-TETRACHLOROSALICYLANILIDE ATPase, Na+/K+ 54% NoneNone NoneNone View
ATPase, (Na+)/K+ transporting, beta 4 polypeptide 3,3',4',5-TETRACHLOROSALICYLANILIDE ATPase, Na+/K+ 54% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 4 polypeptide 3,3',4',5-TETRACHLOROSALICYLANILIDE ATPase, Na+/K+ 54% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 3 polypeptide 3,3',4',5-TETRACHLOROSALICYLANILIDE ATPase, Na+/K+ 54% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 2 polypeptide 3,3',4',5-TETRACHLOROSALICYLANILIDE ATPase, Na+/K+ 54% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 1 polypeptide 3,3',4',5-TETRACHLOROSALICYLANILIDE ATPase, Na+/K+ 54% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 1 polypeptide 3,3',4',5-TETRACHLOROSALICYLANILIDE ATPase, Na+/K+ 54% NoneNone NoneNone View
adrenergic receptor, alpha 2a BUFLOMEDIL Imidazoline I2, Central 54% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) BUFLOMEDIL Imidazoline I2, Central 54% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 AMITRAZ Dopamine Transporter 54% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1B AMITRAZ Serotonin 5-HT1B 54% NoneNone NoneNone View
estrogen receptor 1 ETHISTERONE Estrogen ERalpha 54% NoneNone NoneNone View
estrogen receptor 1 ETHISTERONE Estrogen ERalpha 54% NoneNone NoneNone View
adrenergic receptor, alpha 1a DIPHENIDOL Adrenergic alpha1A 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 PROCHLORPERAZINE Calcium Channel Type L, Benzothiazepine 53% NoneNone NoneNone View
leukotriene B4 receptor 2 PIOGLITAZONE Leukotriene B4 53% 86.922uM 22.055uM View
leukotriene B4 receptor PIOGLITAZONE Leukotriene B4 53% 86.922uM 22.055uM View
leukotriene B4 receptor PIOGLITAZONE Leukotriene B4 53% 86.922uM 22.055uM View
leukotriene B4 receptor 2 PIOGLITAZONE Leukotriene B4 53% 86.922uM 22.055uM View
prostaglandin-endoperoxide synthase 2 PIROXICAM Cyclooxygenase COX-2 53% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) PIROXICAM Cyclooxygenase COX-2 53% NoneNone NoneNone View
melanocortin 4 receptor VINORELBINE Melanocortin MC4 52.5% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel associated protein 1 PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel associated protein 2 PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
Sigma-2 Receptor PROMETHAZINE Sigma2 52% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase TRIOXSALEN CYP450-1A2 Inhibition 52% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 RESVERATROL Dopamine Transporter 52% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 VALDECOXIB Cyclooxygenase COX-1 52% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) VALDECOXIB Cyclooxygenase COX-1 52% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase BAY 11-7085 CYP450-2C19 Inhibition 52% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase DROPERIDOL CYP450-1A2 Inhibition 52% NoneNone NoneNone View
melanocortin 4 receptor EMETINE Melanocortin MC4 52% NoneNone NoneNone View
dopamine receptor 2 DISULFIRAM Dopamine D2L 52% 23.018uM 7.673uM View
5-hydroxytryptamine (serotonin) receptor 2C ALOSETRON Serotonin 5-HT2C 52% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 S-(-)-PROPRANOLOL Calcium Channel Type L, Phenylalkylamine 52% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 S-(-)-PROPRANOLOL Calcium Channel Type L, Phenylalkylamine 52% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 S-(-)-PROPRANOLOL Calcium Channel Type L, Phenylalkylamine 52% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 S-(-)-PROPRANOLOL Calcium Channel Type L, Phenylalkylamine 52% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 S-(-)-PROPRANOLOL Calcium Channel Type L, Phenylalkylamine 52% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 LACIDIPINE Calcium Channel Type L, Phenylalkylamine 51% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 1 polypeptide TRIBROMSALAN ATPase, Na+/K+ 51% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 3 polypeptide TRIBROMSALAN ATPase, Na+/K+ 51% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 2 polypeptide TRIBROMSALAN ATPase, Na+/K+ 51% NoneNone NoneNone View
ATPase, (Na+)/K+ transporting, beta 4 polypeptide TRIBROMSALAN ATPase, Na+/K+ 51% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 4 polypeptide TRIBROMSALAN ATPase, Na+/K+ 51% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 3 polypeptide TRIBROMSALAN ATPase, Na+/K+ 51% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 2 polypeptide TRIBROMSALAN ATPase, Na+/K+ 51% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 1 polypeptide TRIBROMSALAN ATPase, Na+/K+ 51% NoneNone NoneNone View
tachykinin receptor 2 CANDESARTAN Tachykinin NK2 51% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) SB-203580 Protein Tyrosine Kinase, HER2 Receptor 51% 18.896uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) SB-203580 Protein Tyrosine Kinase, HER2 Receptor 51% 18.896uM NoneNone View
androgen receptor CLOMIPHENE Testosterone 51% NoneNone NoneNone View
opioid receptor, kappa 1 DOXAZOSIN Opiate kappa 51% NoneNone NoneNone View
Sigma-2 Receptor DISULFIRAM Sigma2 51% 75.564uM 46.501uM View
Sigma-2 Receptor MOSAPRIDE Sigma2 51% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) BROMOCRIPTINE Protein Tyrosine Kinase, Lck 51% NoneNone NoneNone View
adrenergic receptor, alpha 2a CITALOPRAM Adrenergic alpha2A 51% NoneNone NoneNone View
adrenergic receptor, beta 1 LYSERGOL Adrenergic beta1 51% NoneNone NoneNone View
adrenergic, beta-1-, receptor LYSERGOL Adrenergic beta1 51% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) METHYSERGIDE Adrenergic alpha1D 51% NoneNone NoneNone View
cholinergic receptor, muscarinic 1 LORATADINE Muscarinic M1 51% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE Serotonin 5-HT6 51% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase MC 258717 CYP450-2C19 Inhibition 51% NoneNone NoneNone View
A3 adenosine receptor RWJ-68354 Adenosine A3 51% NoneNone NoneNone View
adrenergic receptor, alpha 1a RWJ-68354 Adrenergic alpha1A 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 MITOTANE Calcium Channel Type L, Dihydropyridine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 MITOTANE Calcium Channel Type L, Dihydropyridine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 MITOTANE Calcium Channel Type L, Dihydropyridine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 MITOTANE Calcium Channel Type L, Dihydropyridine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 MITOTANE Calcium Channel Type L, Dihydropyridine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 MITOTANE Calcium Channel Type L, Dihydropyridine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 MITOTANE Calcium Channel Type L, Dihydropyridine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 MITOTANE Calcium Channel Type L, Dihydropyridine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit MITOTANE Calcium Channel Type L, Dihydropyridine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit MITOTANE Calcium Channel Type L, Dihydropyridine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit MITOTANE Calcium Channel Type L, Dihydropyridine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit MITOTANE Calcium Channel Type L, Dihydropyridine 51% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit MITOTANE Calcium Channel Type L, Dihydropyridine 51% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta ERGOTAMINE Sodium Channel, Site 2 51% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 MOSAPRIDE Calcium Channel Type L, Phenylalkylamine 50% NoneNone NoneNone View
histamine receptor H 2 BROMOCRIPTINE Histamine H2 50% NoneNone NoneNone View
thromboxane A synthase 1 BROMOCRIPTINE Thromboxane Synthetase 50% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) BROMOCRIPTINE Thromboxane Synthetase 50% NoneNone NoneNone View
adenosine A2a receptor MITOTANE Adenosine A2A 50% NoneNone NoneNone View
epidermal growth factor receptor ITRACONAZOLE Protein Tyrosine Kinase, EGF Receptor 50% NoneNone NoneNone View
matrix metallopeptidase 9 GADOPENTETATE DIMEGLUMINE Protease, Matrix Metalloprotease-9 (MMP-9) 50% NoneNone NoneNone View
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) GADOPENTETATE DIMEGLUMINE Protease, Matrix Metalloprotease-9 (MMP-9) 50% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 PHENTOLAMINE Serotonin 5-HT6 50% NoneNone NoneNone View
caspase 1 SULFASALAZINE Protease, Caspase 1 50% 28.812uM NoneNone View
caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) SULFASALAZINE Protease, Caspase 1 50% 28.812uM NoneNone View
caspase 3, apoptosis related cysteine protease SULFASALAZINE Protease, Caspase 1 50% 28.812uM NoneNone View
caspase 2 SULFASALAZINE Protease, Caspase 1 50% 28.812uM NoneNone View
caspase 7 SULFASALAZINE Protease, Caspase 1 50% 28.812uM NoneNone View
caspase 6 SULFASALAZINE Protease, Caspase 1 50% 28.812uM NoneNone View
Cytochrom P450-2D6 monooxygenase DROPERIDOL CYP450-2D6 Inhibition 50% NoneNone NoneNone View
mitogen activated protein kinase 14 ANTIMYCIN A Protein Serine/Threonine Kinase, p38alpha 50% NoneNone NoneNone View
mitogen-activated protein kinase 14 ANTIMYCIN A Protein Serine/Threonine Kinase, p38alpha 50% NoneNone NoneNone View
phosphodiesterase 4A, cAMP specific TROGLITAZONE Phosphodiesterase PDE4 50% NoneNone NoneNone View
phosphodiesterase 4C, cAMP-specific TROGLITAZONE Phosphodiesterase PDE4 50% NoneNone NoneNone View
phosphodiesterase 4D TROGLITAZONE Phosphodiesterase PDE4 50% NoneNone NoneNone View
phosphodiesterase 4B, cAMP specific TROGLITAZONE Phosphodiesterase PDE4 50% NoneNone NoneNone View
arachidonate 15-lipoxygenase CAFFEIC ACID PHENETHYL ESTER Lipoxygenase 15-LO 50% NoneNone NoneNone View
arachidonate 15-lipoxygenase CAFFEIC ACID PHENETHYL ESTER Lipoxygenase 15-LO 50% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide FLAVOXATE Sodium Channel, Site 2 50% NoneNone NoneNone View